CD19 and neoplasm: When this inhibitory anti-CS1 CAR construct was coexpressed with an anti-CD19 CAR on NK cells, cytotoxicity was maintained against CD19+CS1- tumour cells, but cytotoxicity and fratricide against CD19+CS1+ NK cells were inhibited in vitro [Figure 1A].